MED Medifast Inc

  1. Stocks
  2. Consumer Cyclical
  3. NYSE: MED

Price (delayed)

$201.66

Market cap

$2.37B

P/E Ratio

15.75

Dividend/share

$5.39

EPS

$12.8

Enterprise value

$2.19B

Medifast is the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, which offers scientifically developed products, clinically proven plans and the support of Coaches and a ...

Highlights
The EPS has surged by 97% year-on-year and by 20% since the previous quarter
MED's net income has soared by 97% YoY and by 20% QoQ
Medifast's debt has soared by 100% from the previous quarter and by 71% YoY
The company's quick ratio fell by 13% QoQ and by 7% YoY
Sector: Consumer Cyclical
Industry: Personal Services
Website: http://www.medifast1.com
Peers: OPK ABEO

Key stats

What are the main financial stats of MED
Market
Shares outstanding
11.73M
Market cap
$2.37B
Enterprise value
$2.19B
Valuations
Price to earnings (P/E)
15.75
Price to book (P/B)
12.18
Price to sales (P/S)
1.86
EV/EBIT
11.15
EV/EBITDA
10.69
EV/Sales
1.73
Earnings
Revenue
$1.27B
EBIT
$196.74M
EBITDA
$205.17M
Free cash flow
$129.65M
Per share
EPS
$12.8
Free cash flow per share
$11.03
Book value per share
$16.55
Revenue per share
$108.16
TBVPS
$30.99
Balance sheet
Total assets
$364.23M
Total liabilities
$169.55M
Debt
$20.52M
Equity
$194.69M
Working capital
$150.34M
Liquidity
Debt to equity
0.11
Current ratio
1.98
Quick ratio
1.28
Net debt/EBITDA
-0.84
Margins
EBITDA margin
16.1%
Gross margin
74.4%
Net margin
11.8%
Operating margin
15.5%
Efficiency
Return on assets
49%
Return on equity
90.3%
Return on invested capital
1,914.8%
Return on capital employed
93.6%
Return on sales
15.5%
Dividend
Dividend yield
2.67%
DPS
$5.39
Payout ratio
42.1%

MED stock price

How has the Medifast stock price performed over time
Intraday
1.2%
1 week
5.64%
1 month
-3.15%
1 year
36.96%
YTD
2.71%
QTD
4.68%

Financial performance

How have Medifast's revenue and profit performed over time
Revenue
$1.27B
Gross profit
$945.53M
Operating income
$196.76M
Net income
$150.47M
Gross margin
74.4%
Net margin
11.8%
The operating income has soared by 117% YoY and by 20% QoQ
MED's net income has soared by 97% YoY and by 20% QoQ
MED's revenue has surged by 67% year-on-year and by 16% since the previous quarter
Medifast's gross profit has soared by 67% YoY and by 17% from the previous quarter

Growth

What is Medifast's growth rate over time

Valuation

What is Medifast stock price valuation
P/E
15.75
P/B
12.18
P/S
1.86
EV/EBIT
11.15
EV/EBITDA
10.69
EV/Sales
1.73
The EPS has surged by 97% year-on-year and by 20% since the previous quarter
The price to earnings (P/E) is 39% less than the 5-year quarterly average of 25.8 and 26% less than the last 4 quarters average of 21.2
The equity has soared by 67% YoY and by 11% from the previous quarter
MED's P/B is 19% below its last 4 quarters average of 15.0 but 3.2% above its 5-year quarterly average of 11.8
MED's revenue has surged by 67% year-on-year and by 16% since the previous quarter
The P/S is 28% lower than the 5-year quarterly average of 2.6 and 23% lower than the last 4 quarters average of 2.4

Efficiency

How efficient is Medifast business performance
The return on invested capital has dropped by 74% since the previous quarter
The ROA has increased by 33% YoY and by 7% from the previous quarter
MED's ROE is up by 31% YoY and by 6% QoQ
The return on sales has increased by 29% year-on-year and by 4% since the previous quarter

Dividends

What is MED's dividend history
DPS
$5.39
Dividend yield
2.67%
Payout ratio
42.1%
Recent dividends

Financial health

How did Medifast financials performed over time
The total assets is 115% greater than the total liabilities
The total assets has soared by 57% year-on-year and by 12% since the previous quarter
Medifast's total liabilities has increased by 47% YoY and by 12% QoQ
Medifast's debt is 89% less than its equity
Medifast's debt has soared by 100% from the previous quarter and by 71% YoY
Medifast's debt to equity has soared by 83% from the previous quarter and by 10% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.